SCBC_BLK_RD.png
SoCalBio Annual Investor & Partnering Conference Celebrates its 26th Successful Year as Greater Los Angeles’ Biotech/Medtech Industry’s Most Influential Event
October 29, 2024 10:00 ET | Southern California Biomedical Council
LOS ANGELES, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Southern California Biomedical Council (SoCalBio) is proud to conclude the 2024 26th Annual Investor & Partnering Conference in Newport Beach, held...
SCBC_BLK_RD.png
SoCalBio’s 26th Annual Two-Day Investor Partnership Conference hosted at the Hyatt Regency Newport Beach for the Medical Device and Biotechnology Industry
September 18, 2024 13:14 ET | Southern California Biomedical Council
The Southern California Biomedical Council announced the full lineup of speakers and presenting companies for its 26th Annual SoCalBio Investor Conference.
MolecularPartners_Logo.jpg
Molecular Partners and Novartis Report Positive Topline Data from Phase 2 Study for Ensovibep (MP0420), a DARPin Antiviral Therapeutic for COVID-19
January 10, 2022 01:17 ET | Molecular Partners
Topline results from the randomized, placebo-controlled EMPATHY Part A study in acute COVID-19 ambulatory patients comparing single intravenous doses of ensovibep, a DARPin antiviral therapeutic...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients
November 08, 2021 16:05 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...